Pan-Cancer Efficacy of Vemurafenib in BRAF(V)(600)-Mutant Non-Melanoma Cancers

Subbiah, V; Puzanov, I; Blay, JY; Chau, I; Lockhart, AC; Raje, NS; Wolf, J; Baselga, J; Meric-Bernstam, F; Roszik, J; Diamond, EL; Riely, GJ; Sherman, EJ; Riehl, T; Pitcher, B; Hyman, DM

CANCER DISCOVERY, 2020; 10 (5): 657

Abstract

BRAF(V600) mutations occur in a wide range of tumor types, and RAF inhibition has become standard in several of these cancers. Despite this progress, ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索